StockNews.com Downgrades Pediatrix Medical Group (NYSE:MD) to Sell

StockNews.com cut shares of Pediatrix Medical Group (NYSE:MD) from a hold rating to a sell rating in a research note published on Monday.

Several other analysts also recently commented on the stock. Jefferies Financial Group reduced their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a hold rating for the company in a research report on Wednesday, March 6th. Deutsche Bank Aktiengesellschaft raised shares of Pediatrix Medical Group from a sell rating to a hold rating and set a $8.00 price objective for the company in a research report on Friday, June 7th. Finally, Truist Financial reaffirmed a hold rating and set a $10.00 price objective on shares of Pediatrix Medical Group in a research report on Wednesday, May 15th. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, Pediatrix Medical Group has an average rating of Hold and an average price target of $9.10.

Pediatrix Medical Group Stock Up 0.7 %

Pediatrix Medical Group stock opened at $7.70 on Monday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.72 and a current ratio of 1.72. Pediatrix Medical Group has a 52-week low of $6.70 and a 52-week high of $15.02. The firm has a 50 day moving average price of $8.00 and a two-hundred day moving average price of $8.86. The firm has a market cap of $647.96 million, a price-to-earnings ratio of -9.06, a PEG ratio of 1.52 and a beta of 1.54.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.02. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. The firm had revenue of $495.10 million during the quarter, compared to analyst estimates of $496.25 million. Equities analysts predict that Pediatrix Medical Group will post 1.13 EPS for the current year.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of hedge funds have recently made changes to their positions in MD. Vanguard Group Inc. increased its position in shares of Pediatrix Medical Group by 1.6% during the first quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company’s stock valued at $105,892,000 after buying an additional 164,333 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Pediatrix Medical Group by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,409,884 shares of the company’s stock worth $41,013,000 after purchasing an additional 59,336 shares during the last quarter. Pacer Advisors Inc. grew its holdings in shares of Pediatrix Medical Group by 126.9% in the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after purchasing an additional 1,809,828 shares during the last quarter. Boston Partners grew its holdings in shares of Pediatrix Medical Group by 34.0% in the first quarter. Boston Partners now owns 1,786,434 shares of the company’s stock worth $17,702,000 after purchasing an additional 453,254 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Pediatrix Medical Group by 10.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock worth $15,197,000 after purchasing an additional 148,600 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.